Synthesis and antitumor activity of novel chalcone derivatives

Biomedicine and Pharmacotherapy

Volumn 67, Issue 3, 2013, Pages 215-217

  Jin, Chuanfei ^a   Liang, Yong Ju ^b   He, Hongwu ^a   Fu, Liwu ^b  

^a CENTRAL CHINA NORMAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Antitumor activity; Chalcone; Pyrimidine; Synthesis

Indexed keywords

CHALCONE DERIVATIVE; CURCUMIN; FLUOROURACIL;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LEUKEMIA CELL; MOUTH CARCINOMA; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; STOMACH CARCINOMA;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHALCONE; CURCUMIN; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; K562 CELLS; MCF-7 CELLS; NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84875539277     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2010.12.010     Document Type: Article

References (16)

1. Avila H.P., Smania E.F.A., Monache F.D., Junior A.S. Structure-activity relationship of antibacterial chalcones. Bioorg Med Chem 2008, 16:9790-9794.
2. Yang H.M., Shin H.R., Cho S.H., Bang S.C., Song G.Y., Ju J.H., et al. Structural requirement of chalcones for the inhibitory activity of interleukin-5. Bioorg Med Chem 2007, 15:104-111.
3. Svetaz L., Tapia A., Lopez S.N., Furlan R.L.E., Petenatt E., Pioli R., et al. Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi. J Agric Food Chem 2004, 52:3297-3300.
4. Sortino M., Delgado P., Juarez S., Quiroga J., Abonia R., Insuasty B., et al. Synthesis and antifungal activity of (Z)-5-arylidenerhodanines. Bioorg Med Chem 2007, 15:484-494.
5. Dominguez J.N., Leon C., Rodrigues J., Gut J., Rosenthal P.J. Synthesis and Evaluation of New Antimalarial Phenylurenyl Chalcone Derivatives. J Med Chem 2005, 48:3654-3658.
6. Valla A., Valla B., Cartier D., Guillou R.L., Labia R., Florent L., et al. New syntheses and potential antimalarial activities of new retinoid-like chalcones. Eur J Med Chem 2006, 41:142-146.
7. Seo W.D., Ryu Y.B., Curtis-Long M.J., Lee C.W., Ryu H.W., Jang K.C., et al. Evaluation of anti-pigmentary effect of synthetic sulfonylamino chalcone. Eur J Med Chem 2010, 45:2010-2017.
8. 4N-Azabicyclo[3.2.2]nonane thiosemicarbazones derived from acyl diazines. J Med Chem 2001, 44:2164-2171.
9. Dai Y., Hartandi K., Ji Z., Ahmed A.A., Albert D.H., Arnold L., et al. Discovery of N-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor. J Med Chem 2007, 50:1584-1597.
10. Jordan A.M., Khan T.H., Malkin H., Osborn H.M. Synthesis and analysis of urea and carbamate prodrugs as candidates for melanocyte-directed enzyme prodrug therapy (MDEPT). Bioorg Med Chem 2002, 10:2625-2633.
11. Lima L.M., Barreiro E.J. Bioisosterism: a useful strategy for molecular modification and drug design. Curr Med Chem 2005, 12:23-49.
12. Tangeda S.J., Garlapati A. Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives and evaluation of their activities against human colon cancer cell lines. Eur J Med Chem 2010, 45:1453-1458.
13. Mugnaini C., Petricci E., Botta M., Corelli F., Mastromarino P., Giorgi G. Synthesis and biological evaluation of 4-alkylamino-6-(2-hydroxyethyl)-2-methylthiopyrimidines as new rubella virus inhibitors. Eur J Med Chem 2007, 42:256-262.
14. Raffa D., Edler M.C., Daidone G., Maggio B., Merickech M., Plescia S., et al. Synthesis, cytotoxicity, and inhibitory effects on tubulin polymerization of a new 3-heterocyclo substituted 2-styrylquinazolinones. Eur J Med Chem 2004, 39:299-304.
15. Dixson JA, Murugesan N, Barnes KD. US 1992;5149357.
16. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.